Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ATG-018 |
Synonyms | |
Therapy Description |
ATG-018 inhibits ATR, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2604). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ATG-018 | ATG 018|ATG018 | ATR Inhibitor 16 | ATG-018 inhibits ATR, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2604). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05338346 | Phase I | ATG-018 | A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (ATRIUM) | Terminated | AUS | 0 |